AXURA emb départ 7x5,7x10,7x15,7x20mg 28 pce
7680569250202
CH-56925
N06DX01
01.99.0.
Reimbursement limitations:
EBIXA
En début de thérapie, application par ex. d'un test minimental. Première évaluation intermédiaire après trois …
1 / 3
google
Details
- Product number
- 5692506
- CPT
- -
- Packaging group
- 7 + 7 + 7 + 7
- Unit
- Tablette(n)
- Composition
- I) 5 mg: memantini hydrochloridum 5 mg corresp. memantinum 4.15 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, pro compresso obducto corresp., natrium max. 0.3 mg. II) 10 mg: memantini hydrochloridum 10 mg corresp. memantinum 8.31 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (flavum), pro compresso obducto corresp. natrium max. 0.61 mg. III) 15 mg: memantini hydrochloridum 15 mg corresp. memantinum 12.46 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.91 mg. IV) 20 mg: memantini hydrochloridum 20 mg corresp. memantinum 16.62 mg, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto corresp. natrium max. 1.22 mg.
Articles (1)
Axura 5 mg, 10 mg, 15 mg, 20 mg, Filmtabletten
Filmtabletten
7 + 7 + 7 + 7
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
IV
|
20.0 MG | Substance | WIZUS |
|
II
|
10.0 MG | Substance | WIZUS |
|
III
|
15.0 MG | Substance | WIZUS |
|
I
|
5.0 MG | Substance | WIZUS |
|
III
|
12.46 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
8.31 MG | Substance | Wirkstoff (Principe actif) |
|
IV
|
16.62 MG | Substance | Wirkstoff (Principe actif) |
|
I
|
4.15 MG | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
I
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
IV
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
III
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
II
|
- | Substance | FNIDK |
|
I
|
- | Substance | FNIDK |
|
III
|
- | Substance | FNIDK |
|
IV
|
- | Substance | FNIDK |
|
IV
|
- | Substance | FTODK |
|
III
|
- | Substance | FTODK |
|
II
|
- | Substance | FTODK |
|
I
|
- | Substance | HBESI |
|
III
|
- | Substance | FTODK |
|
IV
|
- | Substance | FTODK |
|
II
|
- | Substance | HBESI |
|
III
|
- | Substance | HBESI |
|
IV
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 49.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2010
Authorization holder
Merz Pharma (Schweiz) AG
4123 Allschwil
Authorization information
- Swissmedic authorization number
- 56925
- Drug name
- Axura, Filmtabletten
- Galenic form
- FILM
- ATC Code
- N06DX01
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 19/11/2003
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AXURA emb départ 7x5,7x10,7x15,7x20mg 28 pce
- Description (DE)
- AXURA Starterpack 7x5,7x10,7x15,7x20mg 28 Stk
- Market launch
- 13/08/2012
- Narcotic (BTM)
- No